In 2019, CliniSys | MIPS launched its Genetics LIS, with a successful phase of development and deployment in Europe. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genetics Counselling to clinicians, laboratories, patients and their families.
Kim Futrell, MT(ASCP), MSHI Get more benefits from your point-of-care testing (POCT) program The advantage of quick test results to enable faster clinical decisions is one of the major reasons to implement point-of-care testing (POCT). At a time when hospitals and laboratories are under intense pressure, the benefits of patients accessing tests outside the traditional […]
Molecular, Point-of-Care Abstract Point-of-care testing (POCT) technology continues to advance at a fast pace, making it easier to shrink complex testing platforms into point-of-care (POC) devices. By testing at a molecular level, the accuracy of the results far surpasses previous POCT methodologies. Molecular POCT devices allow quick, easy-to-use testing in near-patient scenarios where a rapid […]
As part of the pandemic management in France, detecting and tracing Covid-19 cases is critical for a successful recovery from the crisis and the protection of the French people. This is the purpose of the national SI-DEP (Système d’Informations de DEPistage) project implemented by the French Ministry of Health and Solidarity, which selected and commissioned CliniSys | MIPS, in partnership with the AP-HP hospital group, for this task. The CyberLab electronic order entry and result consultation system is at the heart of SI-DEP’s IT platform.
New identity for CliniSys and MIPS is launched with refreshed logo and updated website Move reflects 40-year history of delivering industry-leading, end-to-end solutions for customers paired with a commitment to future innovation.
CliniSys Group has created a single brand for the UK and Europe, with a new website, colour palette and logo. What does it all mean for us, our customers and business partners? Michael Simpson, Group Chief Executive Officer explains. Hello and welcome to the new CliniSys | MIPS website! A single name brand for CliniSys […]
Last Updated: 10/08/2022
CHU UCL Namur (B) enhances consistency and performance by implementing the GLIMS LIS across three sites.
“Patient Percentiler”: Ghent University embarks on ambitious, innovative laboratory quality monitoring project using GLIMS.
AZ Turnhout and AZ Herentals (B) laboratories centralise activities with CliniSys | MIPS portfolio.
